Clinical management and outcomes of acute febrile illness in children attending a tertiary hospital in southern Ethiopia.
Antibacterial
Antimalarial
Clinical management
Fever
Outcome
Overprescribing
Pneumonia
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
04 May 2022
04 May 2022
Historique:
received:
31
05
2021
accepted:
27
04
2022
entrez:
5
5
2022
pubmed:
6
5
2022
medline:
7
5
2022
Statut:
epublish
Résumé
The management of febrile illnesses is challenging in settings where diagnostic laboratory facilities are limited, and there are few published longitudinal data on children presenting with fever in such settings. We have previously conducted the first comprehensive study of infectious aetiologies of febrile children presenting to a tertiary care facility in Ethiopia. We now report on clinicians' prescribing adherence with guidelines and outcomes of management in this cohort. We consecutively enrolled febrile children aged 2 months and under 13 years, who were then managed by clinicians based on presentation and available laboratory and radiologic findings on day of enrolment. We prospectively collected outcome data on days 7 and 14, and retrospectively evaluated prescribing adherence with national clinical management guidelines. Of 433 children enrolled, the most common presenting syndromes were pneumonia and acute diarrhoea, diagnosed in 177 (40.9%) and 82 (18.9%), respectively. Antibacterial agents were prescribed to 360 (84.7%) of 425 children, including 36 (34.0%) of 106 children without an initial indication for antibacterials according to guidelines. Antimalarial drugs were prescribed to 47 (11.1%) of 425 children, including 30 (7.3%) of 411 children with negative malaria microscopy. Fever had resolved in 357 (89.7%) of 398 children assessed at day 7, and in-hospital death within 7 days occurred in 9 (5.9%) of 153 admitted patients. Among children with pneumonia, independent predictors of persisting fever or death by 7 days were young age and underweight for age. Antibacterial prescribing in the absence of a guideline-specified indication (overprescribing) was more likely among infants and those without tachypnea, while overprescribing antimalarials was associated with older age, anaemia, absence of cough, and higher fevers. Our study underscores the need for improving diagnostic support to properly guide management decisions and enhance adherence by clinicians to treatment guidelines.
Sections du résumé
BACKGROUND
BACKGROUND
The management of febrile illnesses is challenging in settings where diagnostic laboratory facilities are limited, and there are few published longitudinal data on children presenting with fever in such settings. We have previously conducted the first comprehensive study of infectious aetiologies of febrile children presenting to a tertiary care facility in Ethiopia. We now report on clinicians' prescribing adherence with guidelines and outcomes of management in this cohort.
METHODS
METHODS
We consecutively enrolled febrile children aged 2 months and under 13 years, who were then managed by clinicians based on presentation and available laboratory and radiologic findings on day of enrolment. We prospectively collected outcome data on days 7 and 14, and retrospectively evaluated prescribing adherence with national clinical management guidelines.
RESULTS
RESULTS
Of 433 children enrolled, the most common presenting syndromes were pneumonia and acute diarrhoea, diagnosed in 177 (40.9%) and 82 (18.9%), respectively. Antibacterial agents were prescribed to 360 (84.7%) of 425 children, including 36 (34.0%) of 106 children without an initial indication for antibacterials according to guidelines. Antimalarial drugs were prescribed to 47 (11.1%) of 425 children, including 30 (7.3%) of 411 children with negative malaria microscopy. Fever had resolved in 357 (89.7%) of 398 children assessed at day 7, and in-hospital death within 7 days occurred in 9 (5.9%) of 153 admitted patients. Among children with pneumonia, independent predictors of persisting fever or death by 7 days were young age and underweight for age. Antibacterial prescribing in the absence of a guideline-specified indication (overprescribing) was more likely among infants and those without tachypnea, while overprescribing antimalarials was associated with older age, anaemia, absence of cough, and higher fevers.
CONCLUSION
CONCLUSIONS
Our study underscores the need for improving diagnostic support to properly guide management decisions and enhance adherence by clinicians to treatment guidelines.
Identifiants
pubmed: 35509024
doi: 10.1186/s12879-022-07424-0
pii: 10.1186/s12879-022-07424-0
pmc: PMC9069758
doi:
Substances chimiques
Anti-Bacterial Agents
0
Antimalarials
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
434Informations de copyright
© 2022. The Author(s).
Références
Clin Infect Dis. 2010 Sep 1;51(5):506-11
pubmed: 20642354
Infect Chemother. 2013 Dec;45(4):351-66
pubmed: 24475349
Trans R Soc Trop Med Hyg. 2014 Feb;108(2):61-2
pubmed: 24463580
BMC Infect Dis. 2020 Nov 30;20(1):903
pubmed: 33256629
Lancet Glob Health. 2019 Jan;7(1):e47-e57
pubmed: 30497986
J Pharm Policy Pract. 2014 Nov 14;7(1):15
pubmed: 25838917
Paediatr Child Health. 2014 Jun;19(6):315-25
pubmed: 25332662
Trop Med Int Health. 2011 Jul;16(7):830-7
pubmed: 21470347
Am J Trop Med Hyg. 2015 May;92(5):1030-7
pubmed: 25758648
PLoS One. 2014 Feb 28;9(2):e90179
pubmed: 24587264
PLoS One. 2016 Jan 28;11(1):e0146054
pubmed: 26821179
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33087393
PLoS One. 2014 Aug 04;9(8):e104197
pubmed: 25090651
Health Policy Plan. 2015 Mar;30(2):253-66
pubmed: 24371218
Front Pediatr. 2019 Jan 23;6:425
pubmed: 30729101
BMJ Open. 2013 Jan 24;3(1):
pubmed: 23355663
Infect Dis Poverty. 2018 Nov 05;7(1):103
pubmed: 30392470
J Clin Microbiol. 2017 Jul;55(7):1998-2008
pubmed: 28404671
Malar J. 2017 Jul 4;16(1):271
pubmed: 28676108
Malar J. 2016 Mar 15;15:163
pubmed: 26979286
Open Forum Infect Dis. 2019 Jan 23;6(3):ofz029
pubmed: 30838226
BMJ. 2017 Mar 29;356:j1054
pubmed: 28356302
Int J Health Sci (Qassim). 2016 Apr;10(2):239-48
pubmed: 27103906
Trop Med Int Health. 2016 Jan;21(1):149-156
pubmed: 26544671
Clin Infect Dis. 2008 Mar 15;46(6):926-32
pubmed: 18260752
Malawi Med J. 2016 Dec;28(4):150-153
pubmed: 28321277
Clin Infect Dis. 2017 Jun 15;64(suppl_3):S188-S196
pubmed: 28575369
N Engl J Med. 2014 Feb 27;370(9):809-17
pubmed: 24571753
Lancet. 2015 Dec 5;386(10010):2275-86
pubmed: 26361942
Ann Am Thorac Soc. 2015 Oct;12(10):1482-9
pubmed: 26288389
Malar J. 2019 Sep 27;18(1):331
pubmed: 31558149
BMJ Open. 2020 Jul 21;10(7):e035632
pubmed: 32699131
BMC Public Health. 2017 May 18;17(1):470
pubmed: 28521798
Malar J. 2013 Sep 22;12:340
pubmed: 24053172
Clin Infect Dis. 2011 May;52 Suppl 4:S331-7
pubmed: 21460292